Welcome To Microcore Research Labs India (P) Ltd

Microcore is an R&D-driven biotech company specializing in the discovery, development, and manufacturing of clinically validated specialty nutraceuticals. With a strong scientific foundation and a commitment to innovation, Microcore focuses on creating evidence-based solutions that address chronic and degenerative health conditions. Evolving from a research-focused organization to a fully integrated, innovation-led global enterprise, Microcore offers end-to-end expertise from concept and formulation to manufacturing and clinical validation. This integrated approach ensures that every product meets the highest standards of efficacy, safety, and regulatory compliance.Microcore develops advanced nutraceuticals targeting a wide range of chronic conditions, including Arthritis & Osteoarthritis, Osteoporosis & Osteopenia, Inflammatory Disorders, Rheumatoid Arthritis, Wound Healing & Tissue Regeneration, Hair Health & Skin Care. Backed by GMP-certified manufacturing, robust clinical research, and a strong intellectual property portfolio, Microcore is committed to improving patient outcomes and enhancing quality of life through science-backed nutraceutical innovation.

 

It is a great honor to be ranked and chosen amongst an overwhelming number of 37134 nominations filed by SMEs from all over the country and we are delighted to share our happiness with you that MICROCORE  is a winner of  INDIA SME TOP 100 award 2022

Unit-1 R&D infrastructure, Process development and Production facilities are located at Erode the Textile and Turmeric City of South India. & Unit-2  is under expansion for large scale production of UDCORE-II ( Undenatured Chicken Sternum Collagen Type II) at Tiruchirappalli  to Karur.  Microcore in-house Research and Development initiatives have been formally recognized by the Department of Scientific and Industrial Research (DSIR), Government of India. With a cumulative experience of over 25 years in research, operations, and manufacturing, the organization has consistently demonstrated a strong commitment to innovation and scientific excellence. Notably, Microcore is the only company to hold PA-II approval for its NESM based product range. This distinction underscores the rigorous quality standards and reflects the comprehensive testing and regulatory compliance its products have successfully met.

 

No.01/std/PA/FSSAI/2021
No.02/std/PA/FSSAI/2021
No.02/std/PA/FSSAI/2021 (Part 1)
No.60/std/PA/FSSAI/2022

 

1.Health Claim  :-  Microcore NESM promoting the healthy maintenance of joints and connective tissues.

2.Health Claim :-  Microcore NESC preventing the risk of Osteoporosis.

 

CTRI/2021/08/035335  IPRO 344956, IPRO 566050

CTRI/2023/02/049901  IPRO 344956

 

The approval and sanctioning of Microcore products  through the Form II application marks a significant regulatory milestone. This achievement supported by trademark registrations, granted patents for both the process and product, and exclusive Clinical Trials Registry India (CTRI) registered clinical studies demonstrates a robust and meticulously documented development pathway for the formulation.Furthermore, the production of these nutraceuticals in facilities certified under Good Manufacturing Practices (GMP), ISO-22000, and Halal standards underscores our commitment to safety, efficacy, and consistent product quality critical pillars in the nutraceutical industry. Microcore is presently focused on marketing its branded bio-actives as ingredients, blends, and finished formulations. The company has also conducted comparative clinical studies evaluating Muttaijow Complex® based nutraceutical combinations versus Diacerin based drug combinations in patients with knee osteoarthritis. These research initiatives highlight  strong emphasis on scientific validation, thereby enhancing product credibility and building trust among consumers and healthcare professionals.

 

 

Clinically Studied Branded Bioactives of Microcore

Microcore has  branded Chicken Sternum Collagen Type II & NESM that includes UDCORE -ii ® ,NESC®, Muttaijow Complex® Muttaiodujow®  and clinically validated blends for several indications.

0 +
Years of experiences
0 +
Patents
0 +
Complainces
0 +
Clinicalstudies
0 +
Research Publications
0 +
Brands
0 +
PA-II approval
0 +
Countries

 

 

 

 

 

 

 

 

 

Exclusive Business & Research Partner- India

Akums Drugs  Pharma

Business partnership  with Akums Drugs & Pharmaceuticals to exclusively supply of UDCORE -ii ® , Muttaijow Complex® Muttaiodujow®. The association is  strategic move, leveraging the manufacturing capabilities of Akums, a prominent CRMO (Contract Research and Manufacturing Organization) in India. Akums is a largest CRMO in India, responsible for manufacturing 20% of all drugs and dietary supplements business in India.

Frequently ask Questions

Ask Questions


  •  

  • What are the specialty of Microcore's UDCore-ii?

    Microcore's UDCore-ii, an undenatured Collagen Type II product made from chicken sternum through backward integration. Here's a breakdown of the key points:
    Source and Production: UDCore-ii is derived from chicken sternum.
    It undergoes a production process that adheres to ISO-22000, GMP (Good Manufacturing Practice), FSSAI/CL (Food Safety and Standards Authority of India/Central License), HALAL certifications, and Patent Granted Technologies.
    Specialty: UDCore-ii contains an integrated epitope or antigenicity.
    Undenatured Collagen II is designed to be taken up by Dendritic cells (DCs) in the GALT (Gut-Associated Lymphoid Tissue) in its glycosylated form.
    Immune Response and Oral Tolerance:
    This uptake induces an initial mild immune response. Over time, it leads to the development of oral tolerance. Oral tolerance is characterized by the immune system becoming tolerant to the antigen, in this case, collagen Type II.
    Impact on T Cells: T helper cells recognize the antigen epitopes, contributing to the immune response.
    The immune response is gradually attenuated, suppressing the destructive immune response against cartilage collagen II.
    Stimulation of Regulatory Cells:
    UDCore-ii stimulates T regulatory cells.
    T regulatory cells play a role in suppressing T helper cell stimulation and response. Effects on Collagen Synthesis: The attenuation of the immune response allows for more effective endogenous collagen synthesis.
    Collagen peptide supplementation can be more effective once the inflammatory destruction of cartilage collagen is suppressed.
    Supply Form: UD-Core-ii is not supplied as an independent ingredient. It is provided only as a formulated or finished product.
    This information suggests that Microcore's Undenatured Collagen II has potential applications in modulating the immune response and promoting oral tolerance, which could be beneficial in conditions related to cartilage collagen. It's important to note that the specifics of any medical or health-related use should be discussed with healthcare professionals.

     

  • What are the pipeline  products of Microcore?
     

     Some of our pipeline product includes

    Products

    Products

    High PDAACS protein from  Fried Bengal Gram   Vitamin K27 from fermented Fried Bengal Gram    Medium-chain triglycerides (MCTs) from fermented Coconut oil   Fermented Turmeric Soluble Dietary Fiber from BG Husk Flavorozyme   Anthocyanian from Red Cabbage

  • How to differentiate Microcore's products from Unethical products ?

     

    Microcore would supply the products with clinical Study report and complete regulatory documents directly and we don't have any distributors in  any parts of India, hence please do not relay on low cost suppliers and that would disintegrate the efficacy of your finished products. Microcore's position in the market.
    Intellectual Property Protection: Microcore is the sole company in India holding a patent for the Natural Egg Shell Membrane and Chicken Sternum Collagen Type-II product ranges.
    The company also emphasizes complete regulatory compliance.
    Trademark and Branding: Microcore has registered trademarks for its product ranges.
    Clinical Validation: Microcore promotes branded bioactives that have undergone clinical studies and validation. This implies that their products have been scientifically tested to demonstrate efficacy.
    Distribution Model: Microcore does not have any distributors or agencies for its products.The company seems to have a direct-to-consumer or controlled distribution model.
    Warning About Fake Products: Microcore issues a warning about the presence of fake products being sold at low cost. These fake products are claimed to lack medical advantages.
    Microcore explicitly states that it would not be responsible for any fake products purchased from other companies. Consumers are advised to be cautious and ensure they are purchasing authentic products directly from Microcore to benefit from the claimed medical advantages. The emphasis on patents, trademarks, and clinical validation suggests a commitment to quality and authenticity by Microcore.
     


  •